甲状腺自由素類似体は天然甲状腺自由素分子のコア構造を保持することを目的とし、同時に修飾を導入して安定性、薬物動態学と選択性を増強する。一般的な修飾は、いくつかのアミノ酸の置換またはD-エナンチオマーの使用を含む。
化学原料を購入する必要がある場合は、 要求情報を送信してください最新の見積りを入手してください。
ヒドラジン
DL-Phenylalanine, N-(5-oxo-L-prolyl)-, 2-(3-carboxy-1-oxopropyl)hydrazide
2-ethynyl-9,10-anthraquinone
β-Hydroxy-glutarsaeure-dibenzhydrylester
2,6-diphenyl-1,4-dithiine-1,1,4,4-tetraoxide
4-ブロモ安息香酸クロリド
ピリジン
ベンズアルデヒド
4,8-bis-(4-dodecylphenylethynyl)-2,6-dimethylbenzo[1,2-d-4,5-d']bisoxazole diethylphosphonate ester
FMOC-5-AMINOPENTANOIC ACID
(E)-3-(2-Bromo-phenyl)-acryloyl azide
2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene
4-(2-メチルプロピル)ベンゼンアセトニトリル
6,6'-(1,3,4-oxadiazole-2,5-diyl)bis(2-methylphenol)
2-(1H-benzimidazol-1-ylmethyl)-6-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
8-(2',3'-dihydroxypropyl)-8-phenylmethoxycarbonylamino-1,4-dioxaspiro[4.5]decane
3-(cyclohex-1-enyl)propyl acetate
2-CHLORO-N-PYRAZIN-2-YLACETAMIDE
[(2-amino-2-oxoethyl)thio]acetic acid(SALTDATA: FREE)
rac-<2R,3S(R)>-2-<3-<(chloroacetyl)oxy>-2-oxopropyl>-3-<1-<<(2,2,2-trichloroethoxy)carbonyl>oxy>ethyl>-4-oxo-α-(triphenylphosphoranylidene)azetidine-1-acetic acid (2,2-dimethyl-1-oxopropoxy)methyl ester
tert-Butyl-[(2R,3S)-3-(2-methoxy-ethoxymethoxy)-2-methyl-pent-4-enyloxy]-diphenyl-silane
Benzoic acid, 4-(3-oxo-1-pyrrolidinyl)-, methyl ester
(5Z)-5-(1H-INDOL-3-YLMETHYLENE)IMIDAZOLIDINE-2,4-DIONE
(E)-3-((1S,3R)-1-Benzyloxymethyl-3-hydroxy-4-methyl-pent-4-enyloxy)-acrylic acid ethyl ester
(3R,4R,5R)-3-benzoyloxy-4,5-dihydroxycyclohexanone 4,5-O-cyclohexylidene acetal
(1-Methyl-piperidin-4-yl)-(4-trifluoromethyl-phenyl)-amine
3-deoxyquinic acid
(S)-3-(7-chloro-5-(2-fluorophenyl)-2-thioxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propionic acid methyl ester
C24H22Cl2NPPd
1,3-bis([3,4,5-tris(benzyloxy)benzoyl]oxy)naphthalene
3-phenyl-6-chloro-2-pyranone
6-chloro-5-methyl-2-(piperazin-1-yl)-N-(propan-2-yl)pyrimidin-4-amine
2,4-Pyrrolidinedione, 5-ethyl-3-(1-hydroxyethylidene)-, [S-(Z)]- (9CI)
methyl 3,5-diisopropoxy-4-methoxybenzoate
2-bromo-1-(2-chloro-4-methoxyphenyl)-1-propanone
ベンゾ[b]フェナジン
(2R,5S)-2-(1-oxoethyl)-5-([(1,1-dimethyl)ethyldiphenylsilyl]oxymethyl)tetrahydrofuran
(E)-N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl)-3-(3-fluoro-phenyl)-acrylamide
1,6-Di(cyclohexyl)-hexa-2,4-diin-1,6-diol